Cargando…

Dysphonia after Bevacizumab Rechallenge: A Case Report

Inhibition of vascular endothelial growth factor (VEGF) signaling, an initiator of tumor angiogenesis, inhibits tumor growth and invasion. Bevacizumab, a monoclonal antibody to VEGF, in common use as an adjunct to standard chemotherapy like irinotecan in advanced colorectal cancer, also affects the...

Descripción completa

Detalles Bibliográficos
Autores principales: Carter, Corey A., Caroen, Scott Z., Oronsky, Arnold L., Oronsky, Bryan T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649738/
https://www.ncbi.nlm.nih.gov/pubmed/26600773
http://dx.doi.org/10.1159/000441122

Ejemplares similares